The advisors
YISRAEL M SAFEEK, MD, MBA, FACPE
Founder, Chairman & CEO
The SafeCare Group Lexington, Kentucky |
YISRAEL M SAFEEK, Esq.
Vice Chairman
Attorney Lexington-Fayette Urban County Government (LFUCG) Lexington, Kentucky |
JAMES M FRANCIS, Esq.
Legal Counsel
The SafeCare Group Lexington, Kentucky |
LT. COL. (RET.) NAISHADH BUCH, MBA, PHARMD
Chief Operating Officer
Lompoc Valley Medical Center California |
RUTH W BRINKLEY, RN, MSN, FACHE
President
Kaiser Permanente Mid Atlantic States Rockville, Maryland |
RAY MONTGOMERY, MBA, FACHE
Retired President & CEO
Unity Health Arkansas |
COL. (RET) PETER P MCKEOWN, MD, MBA, MPA, MPH, FACHE, FACS
World-renowned Harvard-trained Heart Surgeon
Kentucky |
NARESH SHAH, PHD
President
TeamLogic IT Lexington, Kentucky |
LINDA M CHRISTMANN, MD, MBA
Former CEO
Montreal Children’s Hospital Florida |
DONALD E LIGHTER, MD, MBA, FACHE
Director
Institute Healthcare Quality Tennessee |
STEVE JACOB, MPH, MA, MSBA
Award-winning
McClatchy Tribune Journalist Texas |
GEORGE E LOFTIN, JR. RN, MBA, FACHE
Vice President of Acute Care Services/Chief Nursing Officer
Parrish Medical Center Florida |
MARK B SAFEEK
Retired Clergy
Texas |
The Truth about Hospital Group Purchasing
The catalyst
Excerpt of interview, SafeCare magazine, 3rd Quarter 2016
Sarju Bharucha, JD, Editor-in-Chief: In all your years working in patient safety, what has surprised you most?
Yisrael Safeek, MD, MBA: The biggest coming to mind is an inspection visit to a “world renowned” hospital when I was with The Joint Commission. When I say “world renowned” I’m referring to a top 10 rating in the nation…rated by others of course. The hospital’s leadership constantly kept reminding the inspection team of these ratings. That all sounds fine until you know that the hospital had over 250 findings after a five day inspection.
They had patient safety lapses like using concentrated heparin to flush central lines, lack of two person handoff from the blood bank, blood administration without staff present in the initial moment, pharmacy not reviewing pre-procedure orders for medications, no post-procedure retrospective review, medications drawn up and mixed in a syringe and stored for later use without the strength of the dose on the label, lack of defined processes for prompt resolution of patient grievances, just to name a few.
I can tell you of another occasion when we …the inspection team…arrived at this great Midwestern health system and was asked to go home. Days earlier ahead of Joint Commission survey, the health system was visited by the Centers of Medicare and Medicaid and had over 1,000 findings. Some involved rape of a patient in a psych ward. Truly sad.
Sarju Bharucha, JD, Editor-in-Chief: In all your years working in patient safety, what has surprised you most?
Yisrael Safeek, MD, MBA: The biggest coming to mind is an inspection visit to a “world renowned” hospital when I was with The Joint Commission. When I say “world renowned” I’m referring to a top 10 rating in the nation…rated by others of course. The hospital’s leadership constantly kept reminding the inspection team of these ratings. That all sounds fine until you know that the hospital had over 250 findings after a five day inspection.
They had patient safety lapses like using concentrated heparin to flush central lines, lack of two person handoff from the blood bank, blood administration without staff present in the initial moment, pharmacy not reviewing pre-procedure orders for medications, no post-procedure retrospective review, medications drawn up and mixed in a syringe and stored for later use without the strength of the dose on the label, lack of defined processes for prompt resolution of patient grievances, just to name a few.
I can tell you of another occasion when we …the inspection team…arrived at this great Midwestern health system and was asked to go home. Days earlier ahead of Joint Commission survey, the health system was visited by the Centers of Medicare and Medicaid and had over 1,000 findings. Some involved rape of a patient in a psych ward. Truly sad.
Board nomination
Opportunity to shape and impact the future of healthcare globally. There are forthcoming opportunities to serve on our distinguished Board of Advisors 2021-2024.
Preferred: Current/prior officer level experience with large and complex organizations with specific skills, connections, resources, and expertise with information technology acquisition - identification, selection, and negotiation of healthcare IT.
Closed July 10 Midnight EST
This material may not be published, rewritten, or redistributed. ©2022 The SafeCare Group. All rights reserved.